Nanobiotix S.A. (ENXTPA: NANO)
Health Care · Biotechnology · FR
€22.34
-0.89% today · +22.6% 1Y
Nanobiotix S.A. (ENXTPA: NANO) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.27B and employs 100 people.
Over the last twelve months the share price has gained 22.6%, trading between 13.10 and 47.66.
Tweenvest scores Nanobiotix S.A. across four factors: quality 32/100, value 62/100. Its strongest factor is value.
NANO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.27B
- Revenue (TTM)
- $13.15M
- P/E
- —
- EPS
- -1.09
- Dividend yield
- —
- Beta (5Y)
- 0.59
- 52-week high
- €47.66
- 52-week low
- €13.10
- Avg volume (3M)
- —
- Shares outstanding
- 50.81M
- Employees
- 100
- Next earnings
- —
About Nanobiotix S.A.
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
- ISIN
- FR0011341205
- Founded
- 2003
- Listed since
- Oct 29, 2012
- Exchange
- Euronext Paris
- Currency
- EUR
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Bio-Thera Solutions, Ltd.SHSE: 688177 | $1.30B | CN¥21.03 | +0.96% |
| Liaoning Chengda Biotechnology Co., Ltd.SHSE: 688739 | $1.29B | CN¥21.02 | +1.94% |
| Everest Medicines LimitedSEHK: 1952 | $1.28B | HK$28.64 | +3.39% |
| Damora Therapeutics, Inc.NasdaqCM: DMRA | $1.27B | $20.56 | -0.44% |
| ORIC Pharmaceuticals, Inc.NasdaqGS: ORIC | $1.27B | $12.03 | -1.43% |
| Nanjing Leads Biolabs Co., Ltd.SEHK: 9887 | $1.25B | HK$50.45 | -3.54% |
| Seegene, Inc.KOSDAQ: A096530 | $1.25B | ₩36,900.00 | +8.53% |
| Savara Inc.NasdaqGS: SVRA | $1.24B | $4.83 | -1.02% |
Figures last refreshed Oct 4, 2026.